The market performance of Fate Therapeutics Inc’s stock has been harmonious in recent times. Over the last year, the company’s stock reached its highest point at $8.83 on 03/07/24, while the lowest value for the same duration was $1.63 on 10/30/23.
52-week price history of FATE Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Fate Therapeutics Inc’s current trading price is -60.93% away from its 52-week high, while its distance from the 52-week low is 111.66%. The stock’s price range during this period has spanned from $1.63 to $8.83. In the Healthcare sector, the Fate Therapeutics Inc’s shares surpassed a trading volume of approximately 0.71 million for the day, which was noticeably lower compared to the average daily volume of 9.1.66 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Fate Therapeutics Inc (FATE) has experienced a quarterly decline of -7.26% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 392.89M and boasts a workforce of 181 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.85, with a change in price of -0.64. Similarly, Fate Therapeutics Inc recorded 1,944,859 in trading volume during the last 100 days, posting a change of -15.65%.
Examining FATE’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for FATE stands at 0.25. Similarly, the long-term debt-to-equity ratio is also 0.24.
FATE Stock Stochastic Average
Today’s raw stochastic average for Fate Therapeutics Inc over the last 50 days is 9.02%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 14.29%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 37.52% and 54.79%, respectively.
FATE Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The metric has seen a significant loss of -7.75% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -49.78%. Over the past 30 days, the price of FATE has leaped by -10.16%. And in the last five days, it has fallen by -13.75%.
